Support Chiropractic Research!

Nutrition

Let’s Talk Supplementation

By |September 2, 2009|Nutrition|

Let’s Talk Supplementation

The Chiro.Org Blog


The debate over using supplements vs. getting “all you need from your diet” has raged on for years. Competent medical professionals are actually telling people that they get everything they need from their diet. Seriously?

What exactly is the “minimum daily requirement” of vitamins? A quick review of the Food Guide Pyramid should make certain things clear:

  1. Those recommended food servings (and it’s a LOT) only provides the MINIMUM vitamins required to avoid getting a vitamin dedficiency disease. WOW, great news. It is NOT enough for a growing child, pregnant woman, or ANYONE who is sick. (more…)

Nutritional Supplementation and JAMA

By |July 22, 2009|Nutrition|

Nutritional Supplementation and JAMA

The Chiro.Org Blog


Editorial Commentary:


In the last few months there has been a disappointing series of nutritional studies published in the Journal of the American Medical Association. JAMA was rabidly opposed to supplementation until 2002, when they published an excellent article that proposed that taking supplements could reduce the risk of chronic disease. [1] That article was right on the money. This recent group of articles challenges those findings, but you will soon find that they were all seriously flawed. Let’s review these clinical trials, and consider how asking the wrong question can yield the wrong answers, and how that process generates negative bias against supplementation.


(more…)

ADD and or ADHD

By |June 22, 2009|ADHD, Attention Deficit, Education, Health, News, Nutrition, Pediatrics, Research, Safety|

ADD and or ADHD

The Chiro.Org Blog


SOURCE:   Am J Psychiatry. 2009 (Sep); 166 (9): 992-1001


This new study revealed that stimulant medications, specifically methylphenidate, are associated with a 6- to 7-times increased risk for sudden death in children and adolescents. UGH!

What does the FDA say about that? “Given the limitation of this study’s methodology, the FDA is unable to conclude that these data affect the overall risk and benefit profile of stimulant medications used to treat attention-deficit/hyperactivity.”

(more…)